Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Clinuvel pharmaceuticals ltd symbols : CLVLF save search
Letter to Shareholders from the Chair (elect) Professor Jeffrey Rosenfeld
Published: 2023-12-14 (Crawled : 02:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: 2.34%
H: 3.08%
C: 3.08%
Change in address for CLINUVEL headquarters
Published: 2023-12-07 (Crawled : 07:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: 0.61%
H: 3.64%
C: 3.64%
change
News Kommuniqué V
Published: 2023-11-30 (Crawled : 18:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: -4.15%
H: 1.77%
C: 1.77%
Application for quotation of securities
Published: 2023-11-27 (Crawled : 07:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: 6.1%
H: 0.0%
C: 0.0%
application
Change of Director’s interest notice — Philippe Wolgen
Published: 2023-11-27 (Crawled : 07:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: 6.1%
H: 0.0%
C: 0.0%
change
Notification of cessation of securities
Published: 2023-11-27 (Crawled : 07:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: 6.1%
H: 0.0%
C: 0.0%
Sydney Soirée — CLINUVEL’s Phase III vitiligo program
Published: 2023-11-10 (Crawled : 03:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: -5.1%
H: 0.0%
C: 0.0%
program
Final director’s interest notice
Published: 2023-11-02 (Crawled : 02:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: -2.18%
H: 3.79%
C: -0.36%
Managing Director’s address
Published: 2023-10-31 (Crawled : 04:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
CLINUVEL appoints new Chair
Published: 2023-10-31 (Crawled : 04:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
News Kommuniqué IV
Published: 2023-10-23 (Crawled : 00:00) - clinuvel.com
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
Clinuvel starts global Phase III vitiligo study
Published: 2023-10-17 (Crawled : 02:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
global study
News Communiqué IV
Published: 2023-10-06 (Crawled : 02:00) - clinuvel.com
CLVLF | $8.9 53.4% 2K
|
Health Technology
|
| O: 11.48%
H: 0.0%
C: 0.0%
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: 0.1%
H: 1.56%
C: 1.56%
CLINUVEL PHARMACEUTICALS LTD Annual General Meeting – Notice of Meeting & Explanatory Memorandum 2023
Published: 2023-09-29 (Crawled : 02:00) - clinuvel.com
CLVLF | $8.9 53.4% 2K
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: 1.31%
H: 0.0%
C: 0.0%
pharmaceuticals meeting
Board changes after AGM
Published: 2023-09-29 (Crawled : 02:00) - clinuvel.com
CLVLF | $8.9 53.4% 2K
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: 1.31%
H: 0.0%
C: 0.0%
CEO letter to shareholders
Published: 2023-09-18 (Crawled : 00:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: -0.24%
H: 0.0%
C: -2.72%
ceo
SCENESSE® in adolescent EPP study
Published: 2023-09-05 (Crawled : 01:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: -3.85%
H: 0.43%
C: -1.39%
scenesse study
Global Vitiligo Treatment Market 2023 - 2028: Ongoing Research and Advocacy Drive Progress
Published: 2023-09-01 (Crawled : 00:20) - prnewswire.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
INCY | $53.725 0.55% 630K
|
Health Technology
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
treatment ongoing research global market
Investor Webinar transcript
Published: 2023-08-30 (Crawled : 06:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: -0.94%
H: 1.89%
C: -2.2%
Afamelanotide Significantly Reduces DNA Damage in a Healthy Population
Published: 2023-08-14 (Crawled : 00:00) - clinuvel.com
CLVLY | $10.0917 1.2K
|
Professional, Scientific, and T...
|
| O: 1.03%
H: 0.0%
C: 0.0%
dna
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
WISA 4 | $5.33 204.57% 190M
|
Electronic Technology
TPET | $0.5189 124.54% 38M
|
n/a
SXTC | $1.78 52.14% 33M
|
Health Technology
JAGX | $0.1771 49.07% 540M
|
Health Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
FNCH | $2.98 32.74% 400K
|
Professional, Scientific, and T...
PALI | $5.51 32.45% 28M
|
Manufacturing
VERO | $0.804 31.8% 110K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.